Curium
Curium leads in nuclear medicine, delivering innovative cancer diagnostics and treatments worldwide. Focused on Neuroendocrine Tumors and prostate cancer, we combine advanced radiopharmaceuticals with AI to enhance imaging and diagnosis. Driven by reliability and innovation, we aim to transform global patient care.
Follow our YouTube channel to stay up-to-date on our company's latest news.
Movember - Prostate Cancer Awareness Month 2024
Opening of our new Lutetium production line in Petten, Netherlands
Curium - Von der Bestellung bis zur Lieferung
St. Louis Triathlon 2024
World Cancer Day 2024 #WCD
Employee Voices - Serge Coupau (full length)
Employee Voices - Serge Coupau (short version)
Employee Voices - Amanda Donovan (full length)
Employee Voices - Amanda Donovan (short version)
Employee Voices - Alexander Fuchs (full length)
Employee Voices - Alexander Fuchs (short version)
Employee Voices - Ryan Wallace (full length)
Employee Voices - Ryan Wallace (short version)
Employee Voices - James Glasgow (full length)
Employee Voices - James Glasgow (short version)
Employee Voices - Isabelle Freile (full length)
Employee Voices - Isabelle Freile - (short version)
Employee Voices - Hikmat Bushnaq-Josting (full length)
Employee Voices - Hikmat Bushnaq-Josting (short version)
Employee Voices - Yvette Whitlock (short version)
Employee Voices - Yvette Whitlock (full length)
Watch the 2022 St. Louis Triathlon Video
64Cu’s short positron range plays a role in high-accuracy imaging - Subtitles
World Cancer Day 2023 - Curium
Employee Voices - Jean Pierre Mandon (short version)
Employee Voices - Julien Del-Tin (short version)
Employee Voices - John Dobma (short version)
Employee Voices - Irene Hazeu (Short version)
Employee Voices - Kathryn Thomas (full length)
Employee Voices - Kathryn Thomas (short version)